title: Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.
abstract: Lysophosphatidic acid (LPA) is a growth factor-like mediator and a ligand for multiple GPCR. The LPA2 GPCR mediates antiapoptotic and mucosal barrier-protective effects in the gut. We synthesized sulfamoyl benzoic acid (SBA) analogues that are the first specific agonists of LPA2, some with subnanomolar activity. We developed an experimental SAR that is supported and rationalized by computational docking analysis of the SBA compounds into the LPA2 ligand-binding pocket.
authors.affiliation: Departments of Pharmaceutical Sciences and ‡Physiology, The University of Tennessee Health Science Center , Memphis, Tennessee 894 Union Avenue 38163 United States.
authors.forename: Renukadevi
authors.initials: R
authors.lastname: Patil
authors.forename: James I
authors.initials: JI
authors.lastname: Fells
authors.forename: Erzsébet
authors.initials: E
authors.lastname: Szabó
authors.forename: Keng G
authors.initials: KG
authors.lastname: Lim
authors.forename: Derek D
authors.initials: DD
authors.lastname: Norman
authors.forename: Andrea
authors.initials: A
authors.lastname: Balogh
authors.forename: Shivaputra
authors.initials: S
authors.lastname: Patil
authors.forename: Jur
authors.initials: J
authors.lastname: Strobos
authors.forename: Duane D
authors.initials: DD
authors.lastname: Miller
authors.forename: Gábor J
authors.initials: GJ
authors.lastname: Tigyi
mesh_terms: D001565:Benzoates / Q000737:chemistry*; D001665:Binding Sites; D060326:Chemistry Techniques, Synthetic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D062105:Molecular Docking Simulation; D049368:Receptors, Lysophosphatidic Acid / Q000819:agonists* / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D001565:Benzoates; D049368:Receptors, Lysophosphatidic Acid; C001910:carzenide
references.citation: J Biol Chem. 2009 May 22;284(21):14558-71
references.pmid: 19293149
references.citation: Biochim Biophys Acta. 2002 May 23;1582(1-3):309-17
references.pmid: 12069842
references.citation: Br J Pharmacol. 2010 Sep;161(2):241-70
references.pmid: 20735414
references.citation: Bioorg Med Chem. 2008 Aug 1;16(15):7218-24
references.pmid: 18656370
references.citation: Gastroenterology. 2007 May;132(5):1834-51
references.pmid: 17484878
references.citation: J Biol Chem. 2005 Oct 14;280(41):35038-50
references.pmid: 16115890
references.citation: J Biol Chem. 2004 Nov 12;279(46):47871-80
references.pmid: 15364923
references.citation: Am J Respir Cell Mol Biol. 2012 Mar;46(3):355-64
references.pmid: 22021336
references.citation: Biochim Biophys Acta. 2013 Jan;1831(1):117-25
references.pmid: 23127512
references.citation: J Med Chem. 2009 Dec 10;52(23):7873-7
references.pmid: 19954251
references.citation: J Biol Chem. 2007 Dec 28;282(52):37759-69
references.pmid: 17965021
references.citation: Mol Pharmacol. 2012 Dec;82(6):1162-73
references.pmid: 22968304
references.citation: Clin Cancer Res. 1999 Dec;5(12):4308-18
references.pmid: 10632375
references.citation: Gastroenterology. 2002 Jul;123(1):206-16
references.pmid: 12105849